Introduced in 2006. Prior to introduction, incidence prior to adolescence approached 90% in US
Vaccine is 85% effective against all disease, 90% effective against severe disease (greater than 1000 lesions)
Typically given at age 5 in USA
Post-exposure prophylaxis:
Ideally given within 3-5 days of exposure in immunocompetent patients
If immunocompromised patient is being given VZIG,<unk>  vaccine should be administered ≥5 months after VariZIG administration
Ideally given within 3-5 days of exposure in immunocompetent patients
If immunocompromised patient is being given VZIG,<unk>  vaccine should be administered ≥5 months after VariZIG administration
Varicella
Atopic dermatitis
Plague
Bed bugs
Rubella
Contact dermatitis
Smallpox
Drug rash